Stanley B. Kaye

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.

Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.

Journal: Gynecologic oncology

Published: November 13, 2017

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Journal: Molecular cancer therapeutics

Published: December 19, 2016

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

Journal: ESMO open

Published: August 27, 2016

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Journal: Nature genetics

Published: December 30, 2015

Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer.

Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer.

Journal: Oncotarget

Published: December 01, 2015

Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?

Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 21, 2015

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 18, 2014

Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?

Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?

Journal: Anticancer research

Published: April 30, 2014

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Journal: Cancer immunology research

Published: April 26, 2014

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 18, 2014

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

Journal: Cancer research

Published: November 26, 2013

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: March 21, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026